Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gelscom
Francegelscom.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Gelscom develops and manufactures CE-marked minimally invasive hydrogel-based medical devices for the treatment of herniated discs. Their flagship product Discogel has demonstrated immediate pain reduction in up to 80% of patients with a nearly 90% success rate for treating cervical, thoracic, and lumbar disc herniation. The company also produces Sclerogel for similar indications.
- Therapeutic areas
- Neurology
- Modalities
- DeviceHydrogel-based drug delivery therapy
- Industry
- Therapeutic Medical Devices
02
Partnerships
Notable distribution partnerships with companies such as ab medica and Medcin Pharma.
Beyond the preview
Go deeper on Gelscom.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gelscom.